Study raises concerns over Servier, Amgen heart drug
Reuters
BARCELONA (Reuters) - A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last year. Ivabradine is not currently approved in the United ...
Heart Rate Drug Tanks in Stable CADMedPage Today

all 5 news articles »


More...